01470nam a2200349 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020001500112040002100127035002100148050002600169082002100195245012800216260005300344300001500397500013000412504005400542533015200596650004300748650002600791650002600817650003800843655002900881700002600910700002200936710001700958856012600975999001901101ebr10056943CaPaEBRm        u        cr cn|||||||||950316s1995    dcu     sb   f000 0 eng    z   95068327   z0309052793  aCaPaEBRcCaPaEBR  a(OCoLC)22806416214aRC848.H44bR48 1995eb04a616.3/62306122000aReview of the Fialuridine (FIAU) clinical trialsh[electronic resource] /cFrederick J. Manning and Morton Swartz, editors.  aWashington, DC :bNational Academy Press,c1995.  aix, 269 p.  a"Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Division of Health Sciences Policy, Institute of Medicine".  aIncludes bibliographical references (p. 165-177).  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aHepatitis BxChemotherapyxEvaluation. 0aFialuridinexTesting. 0aFiacitabinexTesting. 0aClinical trialsxSafety measures. 7aElectronic books.2local1 aManning, Frederick J.1 aSwartz, Morton N.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10056943zAn electronic book accessible through the World Wide Web; click to view  c172101d172101